在前列腺癌退伍军人中,雄激素缺乏后不良事件的种族差异
Nadine A Friedrich1,2,3, Jessica L Janes4, Joshua Parrish4
1Department of Urology, Cedars-Sinai Medical Center, Los Angeles, California.
JAMA network open
|November 19, 2025
概括
抗雄激素剥夺疗法 (ADT) 在所有种族的前列腺癌患者中增加了心血管和骨风险. 虽然黑人和白人患者之间的风险略有不同,但监测对所有人来说都至关重要.
科学领域:
- 在瘤学瘤学.
- 心血管医学 心血管医学
- 骨健康 骨健康 骨健康
背景情况:
- 安卓素剥夺疗法 (ADT) 是一种常见的前列腺癌 (PC) 治疗方法.
- ADT与心脏问题和骨质疏松症等不良事件有关.
- 在ADT的不良事件关联中的种族差异尚未得到充分理解.
研究的目的:
- 评估ADT与心血管和骨相关不良事件之间的关联.
- 确定这些关联是否在PC患者的种族群体之间存在差异.
主要方法:
- 使用退伍军人事务医疗保健系统数据 (2001-2021) 进行了回顾性,全国性,基于人口的队列研究.
- 包括790,916名PC退伍军人,不包括特殊治疗组和缺少种族数据的退伍军人.
- 使用考克斯模型来评估ADT与时间到事件结果的关联,按种族分层.
主要成果:
- 在所有种族中,ADT显著增加了心血管事件 (HR 1.16),骨折 (HR 1.59) 和骨质疏松症 (HR 2.73) 的风险.
- 在黑人患者与白人患者之间,ADT显示心血管事件和骨折的风险略低,但骨质疏松症的风险更高.
- 西班牙裔患者和其他种族患者的风险关联与白人患者相似.
结论:
- 在所有种族的前列腺癌患者中,ADT与心血管和骨风险的增加有关.
- 虽然黑人和白人患者之间存在微小的差异,但整体风险关联是可比的.
- 强调需要对所有接受ADT的患者进行警监测和风险减轻策略.
相关概念视频
Disorders of the Male Reproductive System
3.9K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
3.9K
Comparing the Survival Analysis of Two or More Groups
525
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
525
Cancer Survival Analysis
624
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
624


